公开(公告)号：US20190307859A1

公开(公告)日：2019-10-10

申请号：US16461977

申请日：2017-11-23

申请人： PEPSIS LIMITED

发明人： John Hunter ,  Rosemary Waring

IPC分类号： A61K38/47 ,  A23K10/30 ,  A23K10/38 ,  A23K20/189 ,  A23K20/158 ,  A23K20/24 ,  A23K20/20 ,  A23K50/20 ,  A61K31/20 ,  A61K36/889 ,  A61K31/19 ,  A61K36/185 ,  A61K36/45 ,  A61K31/122 ,  A61K31/366 ,  A61K31/198 ,  A61K31/351 ,  C12Q1/34 ,  C12Q1/40

摘要： The present invention relates to compositions comprising: malt extract including a plurality of enzymatically active enzymes including at least fructanase and amylase; one or more medium-chain triglycerides (MCTs) and/or at least one biologically acceptable metal component and use of those compositions as veterinary and human medicaments

公开(公告)号：US11944668B2

公开(公告)日：2024-04-02

申请号：US16327393

申请日：2017-08-23

申请人： PEPSIS LIMITED

发明人： John Hunter ,  Rosemary Waring

IPC分类号： A61K38/46 ,  A61P1/14

CPC分类号： A61K38/46 ,  A61P1/14

摘要： The invention concerns the improvement of metabolic and digestive health of humans by providing diagnostic methods for enterometabolic disorders such as IBS and IBD and/or the treatment of IBS and IBD by compositions comprising enzyme rich malt extract (ERME).

公开(公告)号：US20210148933A1

公开(公告)日：2021-05-20

申请号：US17041888

申请日：2019-03-26

申请人： PEPSIS LIMITED

发明人： Rosemary Waring ,  John Hunter

IPC分类号： G01N33/68

摘要： The invention concerns a method and assay for qualifying equine laminitis disease status in a subject by measuring specific biomarkers, comparing the level of said biomarker to a control level; and correlating the measurement with laminitis disease status, wherein a statistically relevant elevated level of said biomarker is present in said sample relative to said control level. The invention further relates to immuno-based methods and assays for detecting toxins relevant to laminitis and to the use of antibodies for assay and diagnostic purposes.

公开(公告)号：US20210052707A1

公开(公告)日：2021-02-25

申请号：US16327393

申请日：2017-08-23

申请人： PEPSIS LIMITED

发明人： John Hunter ,  Rosemary Waring

IPC分类号： A61K38/46 ,  A61P1/14

摘要： The invention concerns the improvement of metabolic and digestive health of humans by providing diagnostic methods for enterometabolic disorders such as IBS and IBD and/or the treatment of IBS and IBD by compositions comprising enzyme rich malt extract (ERME).

公开(公告)号：US12005098B2

公开(公告)日：2024-06-11

申请号：US16461977

申请日：2017-11-23

申请人： PEPSIS LIMITED

发明人： John Hunter ,  Rosemary Waring

IPC分类号： C12Q1/40 ,  A23K10/30 ,  A23K10/38 ,  A23K20/158 ,  A23K20/189 ,  A23K20/20 ,  A23K20/24 ,  A23K50/20 ,  A61K9/14 ,  A61K31/122 ,  A61K31/19 ,  A61K31/198 ,  A61K31/20 ,  A61K31/351 ,  A61K31/352 ,  A61K31/366 ,  A61K31/7008 ,  A61K33/06 ,  A61K33/24 ,  A61K36/185 ,  A61K36/45 ,  A61K36/889 ,  A61K38/47 ,  A61K45/06 ,  C12Q1/34

CPC分类号： A61K38/47 ,  A23K10/30 ,  A23K10/38 ,  A23K20/158 ,  A23K20/189 ,  A23K20/24 ,  A23K20/30 ,  A23K50/20 ,  A61K9/14 ,  A61K31/122 ,  A61K31/19 ,  A61K31/198 ,  A61K31/20 ,  A61K31/351 ,  A61K31/352 ,  A61K31/366 ,  A61K31/7008 ,  A61K33/06 ,  A61K33/24 ,  A61K36/185 ,  A61K36/45 ,  A61K36/889 ,  A61K45/06 ,  C12Q1/34 ,  C12Q1/40 ,  C12Y302/01001 ,  C12Y302/01002 ,  C12Y302/0108 ,  A23V2250/00 ,  A23V2250/1578 ,  A23V2250/1586 ,  A23V2250/1612 ,  A23V2250/1878 ,  A23V2250/21 ,  Y02P60/87 ,  A61K33/06 ,  A61K2300/00 ,  A61K33/24 ,  A61K2300/00 ,  A61K31/352 ,  A61K2300/00 ,  A61K31/198 ,  A61K2300/00 ,  A61K31/7008 ,  A61K2300/00 ,  A61K31/122 ,  A61K2300/00 ,  A61K36/185 ,  A61K2300/00 ,  A61K36/45 ,  A61K2300/00

摘要： The present invention relates to compositions comprising: malt extract including a plurality of enzymatically active enzymes including at least fructanase and amylase; one or more medium-chain triglycerides (MCTs) and/or at least one biologically acceptable metal component and use of those compositions as veterinary and human medicaments.